Clinical trials: Bietti Crystalline Dystrophy, open to volunteers
Bietti Crystalline Dystrophy
A Safety Study of Contralateral Eye Dosing of VGR-R01 in Participants With Bietti's Crystalline Dystrophy (BCD)
This is a multi-centre, single- arm, non-randomized, open-label phase 1/2 clinical trial which enables dosing of the fellow eyes of patients who received VGR-R01 administration in previous studies.
- Trial name
- NCT07586306
- Testing
- VGR-R01
- Where
- 2 sites in China
- Volunteers
- 15 people
- Sponsor
- Shanghai Vitalgen BioPharma Co., Ltd.
Bietti's Crystalline Dystrophy, Bietti Crystalline Corneoretinal Dystrophy
ZVS101e in Patients With Bietti's Crystalline Dystrophy
The goal of this clinical trial is to evaluate the safety and early effectiveness of ZVS101e in patients with Bietti crystalline dystrophy who meet the eligibility criteria for treatment under the translational application…
- Trial name
- ZVS101e-BCD (NCT07653971)
- Testing
- ZVS101e
- Where
- 2 sites in China
- Volunteers
- 300 people
- Sponsor
- Chigenovo Co., Ltd
Bietti Crystalline Corneoretinal Dystrophy
Compassionate Administration of ZVS101e for Extended Treatment
To provide treatment options for the control group of subjects who completed the 52-week follow-up of the Phase III clinical trial (Protocol number: ZYA-2024-001) of ZVS101e in subjects with Bietti crystalline corneoretinal…
- Trial name
- NCT07307469
- Testing
- ZVS101e
- Where
- 5 sites in China
- Volunteers
- 32 people
- Sponsor
- Chigenovo Co., Ltd